Market revenue in 2023 | USD 3.3 million |
Market revenue in 2030 | USD 5.5 million |
Growth rate | 7.6% (CAGR from 2023 to 2030) |
Largest segment | Bioavailability & bioequivalence studies |
Fastest growing segment | Bioavailability & Bioequivalence Studies |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Bioavailability & Bioequivalence Studies, Pharmacokinetics, Pharmacodynamics, Other test type |
Key market players worldwide | IQVIA Holdings Inc, Labcorp Holdings Inc, Thermo Fisher Scientific Inc, Pharmaron Beijing Co Ltd Ordinary Shares - Class H, Charles River Laboratories International Inc, Syneos Health, Intertek Group PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell & gene therapy bioanalytical testing services market will help companies and investors design strategic landscapes.
Bioavailability & bioequivalence studies was the largest segment with a revenue share of 36.36% in 2023. Horizon Databook has segmented the Argentina cell & gene therapy bioanalytical testing services market based on bioavailability & bioequivalence studies, pharmacokinetics, pharmacodynamics, other test type covering the revenue growth of each sub-segment from 2018 to 2030.
Argentina has been considered one of Latin America's most advanced countries in terms of regulatory policies. The increasing incidence of diseases and the expansion of vaccine research & manufacturing have made it an economically viable industry. Overall, Argentina has the highest age-standardized cancer incidence in Latin America.
For instance, the WHO reports that in 2022, there were 133,420 new cases of cancer, while the number of deaths was 70,251. The need for better cancer therapies and diagnostics drives R&D in the pharmaceutical and biotechnology industries.
This may result in advancements in cancer treatments, diagnostic equipment, and screening techniques, which are expected to boost the market. Furthermore, biopharmaceutical companies are engaging in a variety of strategic efforts, including partnerships, investments, and M&As, to enhance their market position. Such initiatives are expected to contribute to market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the Argentina cell & gene therapy bioanalytical testing services market , including forecasts for subscribers. This country databook contains high-level insights into Argentina cell & gene therapy bioanalytical testing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account